Material Agreements

NEXTNRG, INC. entered into January 28 SPA with the Purchaser valued at $350,000 (effective 2026-01-28).

“On January 28, 2026, NextNRG, Inc. (the “Company”) entered into a Stock Purchase Agreement (the “January 28 SPA”) with an investor (the “Purchaser”). Pursuant to the terms of the January 28 SPA, the Company agreed to sell, and the Purchaser agreed to purchase, 368,421 shares of the Company’s common stock at a purchase price of $350,000, representing a price per share of $0.95.”

Joby Aviation, Inc. entered into Delta Offering Underwriting Agreement with Morgan Stanley & Co. LLC (effective 2026-01-28).

“On January 28, 2026, the Company also entered into an underwriting agreement (the “Delta Offering Underwriting Agreement”) with Morgan Stanley & Co. LLC, as underwriter, relating to the offer and short sale of 5,286,343 shares of the Company’s common stock, borrowed from third parties in connection with the Note Offering to facilitate hedging transactions”

Joby Aviation, Inc. entered into Indenture with Wilmington Trust, National Association (effective 2026-02-02).

“The Notes were issued pursuant to, and are governed by, an indenture (the “Base Indenture”), dated as of February 2, 2026, between the Company and Wilmington Trust, National Association, as trustee (the “Trustee"), as supplemented by a first supplemental indenture (the “Supplemental Indenture,” and the Base Indenture, as supplemented by the Supplemental Indenture, the “Indenture"), dated as of February 2, 2026, between the Company and the Trustee.”

Joby Aviation, Inc. entered into Note Underwriting Agreement with certain underwriters valued at $600,000,000 principal amount (effective 2026-01-28).

“On January 28, 2026, the Company also entered into an underwriting agreement (the “Note Underwriting Agreement”) with certain underwriters (the “Note Underwriters”) agreeing, subject to customary conditions, to issue and sell $600,000,000 principal amount of the Company’s 0.75% Convertible Senior Notes due 2032 (the “Notes”) (the “Note Offering”) to the Note Underwriters.”

Joby Aviation, Inc. entered into Common Stock Underwriting Agreement with certain underwriters (effective 2026-01-28).

“On January 28, 2026, Joby Aviation, Inc. (the “Company”) entered into an underwriting agreement (the “Common Stock Underwriting Agreement”) with certain underwriters (the “Common Stock Underwriters") agreeing, subject to customary conditions, to issue and sell 52,863,437 shares of the Company’s common stock to the Common Stock Underwriters (the “Common Stock Offering”).”

Scilex Holding Co entered into common stock purchase agreement with Quantum Scan Holdings, Inc. valued at approximately $27.5 million (effective 2026-01-29).

“The Company and Q Scan entered into a common stock purchase agreement, dated January 29, 2026, with Q Scan (the “Stock Purchase Agreement”). Pursuant to the Stock Purchase Agreement, Q Scan agreed to sell to the Company, and the Company agreed to purchase from Q Scan, an aggregate of 193,021,436 shares of Common Stock (the “Stock Purchase”) for an aggregate purchase price of approximately $27.5 million.”

Scilex Holding Co entered into Convertible Promissory Note with Quantum Scan Holdings, Inc. valued at $20 million (effective 2026-01-29).

“Scilex Holding Company (the “Company”) entered into a Convertible Promissory Note, dated January 29, 2026 (the “Note”), with Quantum Scan Holdings, Inc. (“Q Scan”). Pursuant to the Note, the Company loaned Q Scan an aggregate of $20 million.”

Petco Health & Wellness Company, Inc. amended Second Amendment to Credit Agreement with Citibank, N.A., as Administrative Agent and the 2026 Term Loan Lenders valued at $900 million (effective 2026-02-02).

“entered into the Second Amendment to Credit Agreement (the “Amendment”), amending the First Lien Credit Agreement, dated as of March 4, 2021, by and among the Company, the lenders from time to time party thereto and the Administrative Agent (the “Credit Agreement”). Among other changes, the Amendment provides that the Refinancing Lenders will provide term loans (the “Refinancing Term Loans”) to the Company in an aggregate principal amount of $900 million”

SunPower Inc. entered into Share Purchase Agreement with Cobalt Power Systems, Inc. valued at 1.8 million shares of common stock issued at closing; up to additional $6.66 million of shares of co (effective 2026-01-30).

“On January 30, 2026, SunPower Inc., a Delaware corporation (the “ Company ”), entered into a Share Purchase Agreement (the “ Share Purchase Agreement ”) with Cobalt Power Systems, Inc., a California corporation (“ Cobalt ”), and Cobalt’s stockholders (the “ Stockholders ”).”

Janus International Group, Inc. amended Amendment No. 8 with Goldman Sachs Bank USA (as successor to UBS AG, Stamford Branch), as administrative agent and collateral agent and the other parties thereto (effective 2026-02-02).

“On February 2, 2026, Janus International Group, Inc. (the “Company”) completed a repricing pursuant to Amendment No. 8 (the “Repricing Amendment”) to that certain First Lien Credit and Guarantee Agreement (the “First Lien”), dated as of February 12, 2018, by and among Janus Intermediate, LLC, a wholly owned subsidiary of the Company (“Janus Intermediate”), Janus International Group, LLC, a wholly owned subsidiary of the Company (“Janus International”), Goldman Sachs Bank USA (as successor to UBS AG, Stamford Branch), as administrative agent and collateral agent and the other parties thereto.”

Cadre Holdings, Inc. amended Amendment No. 1 to Securities Purchase Agreement with Safariland, LLC and RG Beck AZ, Inc. valued at $145,000,000 aggregate purchase price ($120,000,000 cash + $25,000,000 common stock) (effective 2026-01-29).

“On January 29, 2026, the Company, Safariland, LLC (the “Buyer”), and RG Beck AZ, Inc. (the “Seller”) entered into Amendment No. 1 (the “SPA Amendment”) to the Securities Purchase Agreement”

ESAB Corp entered into Share Purchase Agreement with 9559-2796 Québec Inc., an indirect wholly owned subsidiary, and the Vendors, Holdcos, and Vendors' Representatives party thereto valued at $1.45 billion (effective 2026-01-31).

“On January 31, 2026, ESAB Corporation, a Delaware corporation (the “ Company ”), and 9559-2796 Québec Inc., a corporation governed by the laws of the Province of Québec and a wholly owned indirect subsidiary of the Company (the “ Purchaser ”), entered into a Share Purchase Agreement (the “ Agreement ”) with the vendors party thereto (the “Vendors”), certain holding companies affiliated with certain of the Vendors (the “ Holdcos ”) and the Vendors’ representatives party thereto (the “ Vendors’ Representatives ”)”

Bain Capital Private Credit amended Third Amendment to Senior Secured Revolving Credit Agreement with Sumitomo Mitsui Banking Corporation valued at $575,000,000 to $650,000,000 (effective 2026-01-30).

“On January 30, 2026, Bain Capital Private Credit (the “Company”) entered into the Third Amendment to Senior Secured Revolving Credit Agreement (the “Third Amendment”), which amends that certain Senior Secured Revolving Credit Agreement, dated as of December 29, 2023”

Public Policy Holding Company, Inc. entered into Underwriting Agreement with Oppenheimer & Co. Inc. and Canaccord Genuity LLC (effective 2026-01-27).

“In connection with the IPO, the Company entered into an underwriting agreement (the “Underwriting Agreement”), dated January 27, 2026, by and among the Company, the selling stockholders listed therein and Oppenheimer & Co. Inc. and Canaccord Genuity LLC, as representative of the underwriters”

Newbridge Acquisition Ltd entered into Underwriting Agreement with Kingswood Capital Partners, LLC (effective 2026-01-29).

“an Underwriting Agreement, dated January 29, 2026, by and between the Company and Kingswood Capital Partners, LLC, as representative of the underwriters”

Advanced Biomed Inc. entered into Securities Purchase Agreement with certain investors valued at $248,000 (effective 2026-01-28).

“On January 28, 2026, Advanced Biomed Inc., a Nevada Corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors (the “Investors”) relating to the issuance and sale of 4,000,000 shares of common stock (the “Purchased Shares”), par value $0.001 per share, of the Company (the “Common Stock”), at $0.062 per share for a total purchase price of $248,000 (the “Purchase Price”).”

Toppoint Holdings Inc. entered into Share Purchase Agreement with Cullinan Investor Ltd. valued at 1,200,000 shares of common stock (effective 2026-01-27).

“On January 27, 2026, Toppoint Holdings Inc. (the “Company”) entered into a Share Purchase Agreement (the “SPA”) with Cullinan Investor Ltd., a British Virgin Islands entity (the “Buyer”), and Hok C. Chan, as seller (“Mr. Chan”).”

5C Lending Partners Corp. amended Third Amendment with U.S. Bank National Association (effective 2026-01-30).

“On January 30, 2026, 5C Lending Partners Corp., a Maryland corporation (the “Company”), entered into a third amendment to its revolving credit agreement (the “Third Amendment”), dated as of January 16, 2025 (as amended, supplemented or otherwise modified from time to time, including by the Second Amendment, the “Revolving Credit Agreement”), by and among the Company, U.S. Bank National Association, as Administrative Agent for the Secured Parties, a Letter of Credit Issuer and a Lender.”

Venture Global, Inc. entered into CP2 Phase 2 EPC Contract with Worley Field Services Inc. (effective 2026-01-30).

“On January 30, 2026, Venture Global CP2 LNG, LLC (“CP2”), a wholly-owned subsidiary of Venture Global, Inc. (the “Company”), entered into an engineering, procurement and construction contract (the “CP2 Phase 2 EPC Contract”) with Worley Field Services Inc. (“Worley")”

New ERA Energy & Digital, Inc. amended Amended and Restated Consent and Waiver with ATW AI Infrastructure II LLC valued at Amended and Restated Consent and Waiver modifying anti-dilution provisions of Investor Warrants; adj (effective 2026-02-01).

“On February 1, 2026, New Era Energy & Digital, Inc. (the “ Company ”) entered into an Amended and Restated Consent and Waiver (the “ Amended Waiver ”) with ATW AI Infrastructure II LLC (the “ Investor ”) which amended and restated the previously disclosed Consent and Waiver, dated January 16, 2026, in its entirety.”

Flowco Holdings Inc. entered into Stock Purchase Agreement with Riverway Group valued at aggregate purchase price of approximately $200.0 million (effective 2026-02-01).

“On February 1, 2026, Flowco Holdings Inc. (the “Company”) entered into a Stock Purchase Agreement (the “Purchase Agreement”) by and between the Company and Riverway Group, a Cayman Islands exempted company with limited liability (the “Seller”), pursuant to which the Company agreed to purchase all of the issued and outstanding equity interests of Riverstone Oilfield Services and Equipment, Inc., a Delaware corporation (the “Acquired Company”), from the Seller for an aggregate purchase price of approximately $200.0 million, subject to certain customary adjustments as set forth in the Purchase Agreement (the “Acquisition”), consisting of (i) $170.0 million of cash, subject to adjustment in accordance with the Purchase Agreement, and (ii) 1,454,849 shares of Class A common stock of the Company (“Common Stock,” and such shares issuable, the “Stock Consideration”) to be paid at closing of the Acquisition (the “Closing”).”

KRAKacquisition Corp entered into Registration Rights Agreement with NCTK Sponsor LLC and other Holders (effective 2026-01-27).

“a Registration Rights Agreement, dated January 27, 2026, between the Company, the Sponsor and the other Holders (as defined therein) signatory thereto”

KRAKacquisition Corp entered into Investment Management Trust Agreement with Continental Stock Transfer & Trust Company (effective 2026-01-28).

“an Investment Management Trust Agreement, dated January 28, 2026, between the Company and Continental Stock Transfer & Trust Company, as trustee”

KRAKacquisition Corp entered into Warrant Agreement with Continental Stock Transfer & Trust Company (effective 2026-01-28).

“a Warrant Agreement, dated January 28, 2026, between the Company and Continental Stock Transfer & Trust Company, as warrant agent (the “ Warrant Agreement ”)”

KRAKacquisition Corp entered into Private Placement Warrants Purchase Agreement with NCTK Sponsor LLC (effective 2026-01-27).

“a Private Placement Warrants Purchase Agreement, dated January 27, 2026, between the Company and NCTK Sponsor LLC (the “ Sponsor ”), pursuant to which the Sponsor purchased 2,250,000 private placement warrants, each exercisable to purchase one Class A Ordinary Share at $11.50 per share, at a price of $1.00 per warrant”

KRAKacquisition Corp entered into Underwriting Agreement with Santander US Capital Markets LLC (effective 2026-01-27).

“Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement: ● an Underwriting Agreement, dated January 27, 2026, between the Company and Santander US Capital Markets LLC, which contains customary”

Xsolla SPAC 1 entered into Underwriting Agreement with D. Boral Capital LLC valued at Underwriting Agreement dated January 28, 2026; gross proceeds of $200,000,000 from IPO of 20,000,000 (effective 2026-01-28).

“Underwriting Agreement, dated January 28, 2026, by and between the Company and D. Boral Capital LLC, as representative of the underwriters, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference”

DONALDSON Co INC entered into Securities Purchase Agreement with Facet Group Holdings II LLC and Facet Holdings II B.V. valued at $820 million (effective 2026-01-31).

“On January 31, 2026, Donaldson Company, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with Facet Group Holdings II LLC”

NORDSON CORP entered into Amended and Restated Credit Agreement with Wells Fargo Bank, National Association, as a lender and as Administrative Agent for the lenders valued at $1,200 million (effective 2026-01-30).

“On January 30, 2026, Nordson Corporation (the “Company”) entered into an Amended and Restated Credit Agreement (the “Revolving Credit Agreement”) with its subsidiary, Nordson Engineering GmbH, a private limited liability company organized and existing under the laws of Germany, registered with the commercial register of the local court of Lüneburg under number HRB 999 (“Nordson GmbH”), with Wells Fargo Bank, National Association, as Administrative Agent (the “Revolving Agent”), various financial institutions named therein as lenders and Wells Fargo Securities, LLC, BofA Securities, Inc., BNP Paribas Securities Corp., JPMorgan Chase Bank, N.A., Morgan Stanley Senior Funding, Inc., and PNC Capital Markets LLC, as Joint Lead Arrangers and Joint Bookrunners.”

Dalrada Technology Group, Inc. entered into Credit, Security, and Account Purchase Agreement with IBS Equity Fund III, LLC (or its affiliate, IBS Private Credit Fund IV, LLC) valued at $5,000,000 (effective 2025-12-31).

“The SBLC Agreement supports a related Credit, Security, and Account Purchase Agreement (the "ARL Agreement") dated the same day, under which the Secured Party (or its affiliate, IBS Private Credit Fund IV, LLC) may extend revolving credit through the purchase of accounts receivable on behalf of Genefic for the benefit of third-party beneficiaries in connection with Genefic's business operations, up to $5,000,000.”

Dalrada Technology Group, Inc. entered into Master Performance Standby Letter of Credit and Guaranty Agreement with IBS Equity Fund III, LLC, a division of IBS Investment Bank valued at $20,000,000 (effective 2025-12-31).

“On January 21, 2026, Genefic Inc. ("Genefic"), a wholly-owned subsidiary of Dalrada Technology Group, Inc. (the "Company"), entered into a Master Performance Standby Letter of Credit and Guaranty Agreement dated December 31, 2025 (the "SBLC Agreement") with IBS Equity Fund III, LLC, a division of IBS Investment Bank (the "Secured Party").”

Coterra Energy Inc. entered into Agreement and Plan of Merger with Devon Energy Corporation (effective 2026-02-01).

“On February 1, 2026, Coterra Energy Inc., a Delaware corporation (the “ Company ” or “ Coterra ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), with Devon Energy Corporation, a Delaware corporation (“ Devon ”), and Cubs Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Devon (“ Merger Sub ”).”

ONITY GROUP INC. entered into Second Supplemental Indenture with Wilmington Trust, National Association valued at $200 million aggregate principal amount of 9.875% Senior Notes due 2029 (effective 2026-01-30).

“On January 30, 2026, Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) announced that its subsidiaries PHH Corporation (“PHH”) and PHH Escrow Issuer LLC (the “Escrow Issuer” and together with PHH, the “Issuers”) completed the issuance and sale of $200 million aggregate principal amount of 9.875% Senior Notes due 2029 (the “PHH Senior Notes”).”

HAIN CELESTIAL GROUP INC entered into Asset Purchase Agreement with Snackruptors Inc. with Snackruptors Inc. valued at $115 million in cash (effective 2026-01-30).

“On January 30, 2026, The Hain Celestial Group, Inc. (“Hain”) entered into an asset purchase agreement (the “Purchase Agreement”) with Snackruptors Inc. (“Snackruptors”), pursuant to which, subject to the terms and conditions set forth therein, Snackruptors has agreed to acquire from Hain its North American Snacks business, including Garden Veggie SnacksTM, Terra® chips and Garden of Eatin’® snacks as well as certain private label products (the “Business”) for $115 million in cash, subject to a customary inventory adjustment (the “Transaction”).”

GIBRALTAR INDUSTRIES, INC. terminated Existing Credit Facility with KeyBank National Association, as administrative agent, and the other lenders and parties.

“On the Closing Date, Gibraltar terminated its Credit Agreement, dated as of December 8, 2022 (as amended, restated, supplemented or otherwise modified prior to the Closing Date, the “ Existing Credit Facility ”), by and among Gibraltar, the other borrowers party thereto, the lenders and other parties party thereto and KeyBank National Association, as administrative agent, and repaid all amounts outstanding thereunder.”

GIBRALTAR INDUSTRIES, INC. entered into Credit Agreement with Bank of America, N.A., as administrative agent and collateral agent, and the other financial institutions from time to time party thereto.

“On the Closing Date, Gibraltar entered into a new credit agreement (the “ Credit Agreement ”), as borrower, together with Bank of America, N.A., as administrative agent and collateral agent, and the other financial institutions from time to time party thereto.”

CENTURY ALUMINUM CO entered into Purchase and Sale Agreement with Justified DataPower LLC valued at Two Hundred Million dollars ($200,000,000) in cash (effective 2026-02-02).

“On February 2, 2026, Century Aluminum of Kentucky General Partnership, a Kentucky general partnership (“CAKY”) and Justified DataPower LLC, a Delaware limited liability company (“Purchaser”), entered into an agreement of purchase and sale (the “Purchase and Sale Agreement”)”

NRG ENERGY, INC. entered into Registration Rights Agreement with the Sellers.

“On the Closing Date, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Sellers, who received Stock Consideration (as defined below) in the Transaction”

Comstock Inc. entered into Underwriting Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC valued at approximately $50.0 million (effective 2026-01-28).

“On January 28, 2026, Comstock Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC, as underwriter (the “Underwriter”), pursuant to which the Company agreed to sell 18,181,819 shares (the “Shares”) of the Company’s common stock, par value $0.000666 per share (“Common Stock”), less underwriting discounts and commissions.”

MADRIGAL PHARMACEUTICALS, INC. amended First Amendment to the Research, Development, and Commercialization Agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (together, “Roche”) (effective 2026-01-29).

“On January 29, 2026 (the “Effective Date”), Madrigal Pharmaceuticals, Inc. (the “Company”), F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. (together, “Roche”) entered into the First Amendment (the “Amendment”) to the Research, Development, and Commercialization Agreement dated as of December 18, 2008 between the Company and Roche.”

ProMIS Neurosciences Inc. entered into Registration Rights Agreement with each of the PIPE Investors.

“In connection with the Securities Purchase Agreement, the Company entered into a Registration Rights Agreement with each of the PIPE Investors (the “ Registration Rights Agreement ”), pursuant to which the Company is required to prepare and file a registration statement (the “ Registration Statement ”) with the Securities and Exchange Commission (the “ SEC ”) under the Securities Act, covering the resale of the Common Shares issued to the PIPE Investors under the Securities Purchase Agreement, together with the Warrant Shares.”

ProMIS Neurosciences Inc. entered into Securities Purchase Agreement with selected investors that qualify as "accredited investors" valued at approximately $75 million (effective 2026-01-29).

“On January 29, 2026, ProMIS Neurosciences Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with selected investors that qualify as “accredited investors” (the “ PIPE Investors ”), as defined in Rule 501(a) of Regulation D promulgated under the United States Securities Act of 1933, as amended (the “ Securities Act ”), for the purpose of raising approximately $75 million in aggregate gross proceeds for the Company (the “ Offering ”) before deducting placement agent fees and other expenses payable by the Company.”

SARATOGA INVESTMENT CORP. entered into Underwriting Agreement with Lucid Capital Markets, LLC, as representative of the several underwriters valued at $100,000,000 aggregate principal amount (effective 2026-01-29).

“On January 29, 2026, Saratoga Investment Corp. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company and Saratoga Investment Advisors, LLC, on the one hand, and Lucid Capital Markets, LLC, as representative of the several underwriters named in Schedule I thereto, on the other hand, in connection with the issuance and sale of $100,000,000 aggregate principal amount of the Company’s 7.50% Notes due 2031”

PENNANTPARK INVESTMENT CORP entered into Note Purchase Agreement with a qualified institutional investor valued at $75,000,000 (effective 2026-01-30).

“On January 30, 2026, PennantPark Investment Corporation (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) governing the issuance of $ 75,000,000 in aggregate principal amount of 7.00% Senior Unsecured Notes due February 1, 2029 (the “Notes”), to a qualified institutional investor (the “Investor”) in a private placement (the “Private Placement”).”

INVO Fertility, Inc. entered into Inducement Letter Agreement with an institutional investor and existing holder valued at approximately $7.5 million (effective 2026-01-28).

“On January 28, 2026, INVO Fertility, Inc. (the “Company”) entered into an inducement letter agreement (the “Inducement Letter Agreement”) with an institutional investor and existing holder (the “Holder”) of certain existing warrants (the “Existing Warrants”) to purchase up to 4,733,728 shares of the Company’s common stock (the “Common Stock”).”

Nuwellis, Inc. entered into Private Placement Purchase Agreement with a certain institutional accredited investor valued at combined purchase price of $3.09 (effective 2026-01-29).

“On January 29, 2026, Nuwellis, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Private Placement Purchase Agreement ”) with a certain institutional accredited investor (the “ Purchaser ”) in connection with a private placement (the “ Private Placement ”) for the offer, issuance and sale of (i) 994,537 pre-funded common stock purchase warrants (the “ Pre-Funded Warrants ”) to purchase up to 994,537 shares (the “ Pre-Funded Warrant Shares ”) of the Company’s common stock, $0.0001 par value (the “ Common Stock ”) and (ii) 1,989,074 common warrants (the “ Common Warrants ”, and together with the Pre-Funded Warrants, the “ Private Placement Warrants ”) to purchase up to 1,989,074 shares of Common Stock (the “ Common Warrant Shares ” and together with the Pre-Funded Warrant Shares and the Pre-Funded Warrants, the “ Securities ”) for a combined purchase price of $3.09.”

CIVITAS RESOURCES, INC. terminated Civitas Credit Agreement with JPMorgan Chase Bank, N.A. (effective 2026-01-30).

“On January 30, 2026, concurrently and in connection with the Mergers, Civitas terminated all commitments, and caused to be repaid in full all indebtedness, liabilities and other obligations, under that certain Amended and Restated Credit Agreement dated November 1, 2021”

Akebia Therapeutics, Inc. entered into Lease Agreement with BP THIRD AVENUE LLC valued at Annual rent for Office Premises initially $898,317, for Lab Premises initially $1,046,920, with rent (effective 2026-01-27).

“On January 27, 2026, Akebia Therapeutics, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with BP THIRD AVENUE LLC, a Delaware limited liability company (the “Landlord”), pursuant to which the Company will lease an aggregate of approximately 43,474 square feet, consisting of 28,518 square feet of office space (the “Office Premises”) and 14,956 square feet of laboratory space (the “Lab Premises”) located at the building commonly known as 180 CityPoint and numbered 180 Third Avenue, Waltham, Massachusetts 02451”

Beeline Holdings, Inc. amended Letter Agreement with holder of Series A Convertible Redeemable Preferred Stock (effective 2026-01-27).

“On January 27, 2026, Beeline Holdings, Inc. (the “Company”) entered into an agreement (the “Letter Agreement”) with the holder of Series A Convertible Redeemable Preferred Stock (the “Series A”) pursuant to which the parties agreed to an amendment to the Certificate of Designations, Preferences and Rights of the Series A Convertible Redeemable Preferred Stock”

VYNE Therapeutics Inc. amended Amendment to Agreement and Plan of Merger and Reorganization with Yarrow Merger Sub Corp. and Yarrow Bioscience, Inc. (effective 2026-01-30).

“On January 30, 2026, VYNE Therapeutics Inc., a Delaware corporation (“VYNE”), Yarrow Merger Sub Corp., a Delaware corporation and a wholly-owned subsidiary of VYNE (“Merger Sub”), and Yarrow Bioscience, Inc., a Delaware corporation (“Yarrow”), entered into an amendment (the “Amendment”) to that certain Agreement and Plan of Merger and Reorganization, dated December 17, 2025 (as amended, the “Merger Agreement”), by and among VYNE, Merger Sub and Yarrow.”